Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.
The Biogen-developed treatment, called lecanemab, appears to have a more clear-cut effect on slowing the disease than the company’s previous Alzheimer’s drug, Aduhelm.
Scientists study pluripotent stems cells to understand early development and how to use them in regenerative medicine, disease modeling, and drug discovery.
Mahi-mahi were more likely to be eaten and less likely to spawn after being exposed to sublethal concentrations of oil, raising concerns about the risks oceanic drilling pose to life in the ocean.
Researchers found that naturally-occurring CD7-negative T cells avoid self-destruction and are good effectors in CAR T therapy for T cell blood cancers.
Researchers determined the safety and antitumor ability of genetically engineered CAR T cells that circumvent immune suppression in a prostate cancer phase I clinical trial.
A protein duo increases transcription of growth-related genes to enhance axon regeneration and boost plasticity, a study finds—but fails to improve mobility.
![jigsaw puzzle with magnifying glass over the word "metastasis" ](https://cdn.the-scientist.com/assets/articleNo/70540/aImg/47882/49929-800x5607-t.jpg "jigsaw puzzle with magnifying glass over the word "metastasis" ")
